According to stock market observers, shares of the company are available at a premium of ₹242 in the grey market today ...

The subscription for Senores Pharmaceuticals IPO opened on December 20 and closed on December 24. Senores Pharmaceuticals IPO ...

The basis of allotment for Senores Pharmaceuticals IPO shares is set to be finalised on Thursday, December 26, 2024.

Investors can check their allotment status through multiple platforms such as NSE, BSE and also through the registrar’s ...

After finalising the share allotment status, the company will initiate refunds and transfer of shares to the demat accounts ...

Learn how to track your share allotments and discover the latest grey market premiums indicating potential listing prices for ...

Unlisted shares of Senores Pharmaceuticals were trading at Rs 631 per share, reflecting a GMP of Rs 240 per share or 61.38 ...

Investors who subscribed to the Senores Pharma IPO can check their allotment status on the official website of the registrar, Link Intime.

Senores Pharmaceuticals IPO sees robust demand, with potential listing gain of 59%, scheduled to list on BSE and NSE.

The Senores Pharmaceuticals' public issue will close for public bidding on Tuesday, December 24. The IPO has received 13.93x ...

The grey market premium of Senores Pharmaceuticals IPO was Rs 240 as of 05:04 a.m. on Dec. 26, indicating a strong gain of 61 ...

Senores Pharmaceuticals IPO sees high demand; allocation on Dec 26, GMP suggests strong listing. Stay informed!